Product Details
2025-2026 Flucelvax® 5 ml multi-dose vial², FLU-108, 10 Doses/Vial
Manufacturer: SEQIRUS, INC.
MFG#: FLU2015003
PID: 638977
1/VL
$442.78
Out of StockAdditional Information
| Product Name | Flucelvax® 2025–2026 (Flu-108) |
| Type of Vaccine | Cell-based inactivated quadrivalent influenza vaccine (ccIIV4) |
| Vaccine Strains | 2 Influenza A strains + 2 Influenza B strains (2025–2026 formulation) |
| Dosage Form | 5 mL Multi-Dose Vial |
| Presentation | 10 Doses per Vial (0.5 mL each) |
| Age Group | 6 months and older |
| Route of Administration | Intramuscular injection |
| Injection Site | Deltoid (adults) or anterolateral thigh (infants) |
| Preservatives | Contains thimerosal |
| Common Side Effects | Pain at injection site, headache, fatigue, muscle ache |
| Serious Risks | Rare: anaphylaxis, Guillain-Barré syndrome |
| Storage Conditions | 2°C to 8°C (36°F to 46°F); do not freeze |
| Use After Puncture | Within 28 days |
| Packaging | Single 5 mL vial per carton |
| Indication | Prevention of influenza A and B |
Description
Flucelvax® 2025–2026 (Flu-108) is a cell-based quadrivalent influenza vaccine intended for active immunization against influenza A and B virus strains expected during the 2025–2026 influenza season. Unlike egg-based vaccines, it is manufactured using Madin-Darby Canine Kidney (MDCK) cells, which helps avoid egg-adapted mutations and may provide a closer antigenic match to circulating strains.
The vaccine is supplied as a 5 mL multi-dose vial, containing ten 0.5 mL doses. It is approved for individuals aged 6 months and older. Each dose is administered intramuscularly, typically into the deltoid muscle in adults and older children or into the anterolateral thigh in infants. Flucelvax® does not contain a live virus and cannot cause influenza illness.
Common adverse effects include injection site pain, swelling, redness, muscle aches, headache, and fatigue. Fever, irritability, and malaise may occur in younger populations. Rare but serious risks include hypersensitivity reactions and Guillain-Barré syndrome. The vaccine is contraindicated in individuals with a history of severe allergic reaction to any vaccine component.
Frequently Asked Questions (FAQs)
The cost of 2025-2026 Flucelvax® 5 ml multi-dose vial², FLU-108, 10 Doses/Vial is $$442.78
2025-2026 Flucelvax® 5 ml multi-dose vial², FLU-108, 10 Doses/Vial is manufactured by SEQIRUS, INC..
You can purchase 2025-2026 Flucelvax® 5 ml multi-dose vial², FLU-108, 10 Doses/Vial on our website at https://supplies.pipelinemedical.com/product/detail/2025-2026-flucelvax®-5-ml-multi-dose-vial²-flu-108-10-doses-vial-638977